Lauren Floyd
LightNews LightNews
doclfloyd.bsky.social
Lauren Floyd
@doclfloyd.bsky.social
44 followers 61 following 0 posts
Renal Reg in North West, UK / Research interests in Vasculitis and GN / ERA YNP Board member
Posts Replies Media Videos
Reposted by Lauren Floyd
nephjc.bsky.social
As we welcome 2025 and say goodbye to 2024- another amazing year in nephrology- you the #NephJC community voted for them...
Here are the top NEPHROLOGY stories of 2024! Join us 9pm EST on 1/7/25 as we chat about what were practice and life changing events of the past year. #NephSky #MedSky
January 1, 2025 at 4:09 PM
Reposted by Lauren Floyd
sodatroubles.bsky.social
Belimumab versus telitacicept in sequential treatment after rituximab for refractory #lupus nephritis: a real-world multicentre study
#nephsky
lupus.bmj.com/content/12/1...
Belimumab versus telitacicept in sequential treatment after rituximab for refractory lupus nephritis: a real-world multicentre study
Objective Both belimumab and telitacicept are recognised blockers for B lymphocyte activation, both of which have been approved as add-on therapies for SLE in China. The aim of this study is to compar...
lupus.bmj.com
January 9, 2025 at 8:17 PM
Reposted by Lauren Floyd
kdigo.org
🌟 KDIGO is now on Bluesky! 🌟

We’re excited to connect with the nephrology community on this platform and share the latest from KDIGO, including guidelines, reports, and educational resources.

We’d like to introduce KDIGO, what we do, and how to connect with us. 🧵👇

🔗 kdigo.org

#NephSky
January 9, 2025 at 7:44 PM